Carregant...
Views of European Drug Development Stakeholders on Treatment Optimization and Its Potential for Use in Decision-Making
BACKGROUND: The current drug development paradigm has been criticized for being too drug-centered and for not adequately focusing on the patients who will eventually be administered the therapeutic interventions it generates. The drug-driven nature of the present framework has led to the emergence o...
Guardat en:
| Publicat a: | Front Pharmacol |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7015135/ https://ncbi.nlm.nih.gov/pubmed/32116718 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.00043 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|